Loading...

425 posters, 1 videos, 9 audios, 8 topics, 53 sessions, 340 authors, 286 institutions

ePostersLive by SciGen Technologies S.A. All rights reserved.

22nd Annual Pain Medicine Meeting 2023

November 10 - 11, 2023 | New Orleans Marriott | New Orleans, Louisiana, USA

22nd Annual Pain Medicine Meeting 2023 banner

4983

INTERCOSTAL RADIOFREQUENCY ABLATIONS: A PROMISING THERAPY FOR REFRACTORY INTERCOSTAL NEURALGIA

Poster Presenter

Riju Dasgupta

Part of Topic

Medically Challenging Cases

  • Intercostal neuralgia is a painful condition characterized by sharp, shooting, or burning pain along the distribution of an intercostal nerve
  • Most commonly presents after thoracotomies, breast surgeries, nerve entrapment, neuromas, or with herpes zoster
  • Conventional therapies include NSAID’s, neuropathic, narcotics, and intercostal nerve blocks
  • Case reports have demonstrated that radiofrequency ablations (RFA) can provide benefit to patients refractory to conventional treatments
  • 64 year old man presents with chronic right sided rib pain secondary to lung adenocarcinoma treated with radiation therapy
  • At initial evaluation, patient was taking 100 mcg/hr fentanyl transdermal patches every three days, daily dose of 40 mg of oxycodone/acetaminophen, and gabapentin 300 mg TID
  • Initially responded favorably to intercostal nerve blocks from T7 to T9 with 0.25% bupivicaine and triamcinolone for several months
  • Repeat intercostal nerve blocks  provided smaller durations of relief for patient
  • Thermal RFA was then performed at the T7-9 levels on the right side
  • RFA provided long lasting relief which is currently ongoing
  • Patient was able to reduce opioid consumption to just 37.5/hr mcg fentanyl patch with complete cessation of his oxycodone/acetaminophen
  • Case demonstrates another potential use of RFA in non-axial pain states
  • Literature review up to date has demonstrated at least 14 applications of intercostal RFA with positive and durable outcomes for patients
  • Prior case reports predominantly present patients with intercostal neuralgia secondary to surgical sequelae as opposed to radiation or neoplastic induced intercostal neuralgia
  • Intercostal RFA was crucial in regards to reducing patients opioid dose from 300 morphine milligram equivalents (MME)/day to 90 MME/day
  • Further large scale studies are warranted to further elucidate and define the overall benefits, risks, and potential sequelae of this procedure
22nd Annual Pain Medicine Meeting 2023 » banner
Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.